Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
OPTN | OptiNose, Inc. | Chief Financial Officer | $131K | Oct 7, 2024 | ||
VRCA | Verrica Pharmaceuticals Inc. | Chief Financial Officer | $110K | -$77.5K | -41.3% | Aug 26, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|